News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about SciSparc
Recent news which mentions SciSparc
Clearmind Medicine Files International Patent For Ibogaine Combination Therapy
September 17, 2024
Tickers
CMND
NEWS
SPRC
Tags
News
Health Care
Market News
From
Benzinga
SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 22, 2023
Tickers
BIDU
DE
EVS
MARA
Tags
Marathon Digital
Trending stocks
Cryptocurrency
From
Benzinga
SciSparc Signs LOI to Sell 50% Interest in Subsidiary
December 15, 2022
Tickers
JFBR
SPRC
Tags
SciSparc
Market News
Penny Stocks
From
Benzinga
Can This Company's Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?
November 15, 2022
Tickers
AMPH
Tags
General
Cannabis
Markets
From
Benzinga
SciSparc Nutraceuticals Signs Agreement With Logistics Facilities, Expected To Optimize Handling and Shipment Processes and Reduce Direct Sales Costs
November 02, 2022
Tickers
SPRC
Tags
Market News
SciSparc
Benzinga
From
Benzinga
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
September 14, 2022
Tickers
SPRC
Tags
SPRC
Press Releases
Penny Stocks
From
Benzinga
Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration
August 25, 2022
Tickers
CMNDF
SPRC
Tags
Market News
SciSparc
SPRC
From
Benzinga
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
August 25, 2022
Tickers
CMNDF
SPRC
Tags
CMNDF
General
Biotech
From
Benzinga
Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know
August 24, 2022
Tickers
CMNDF
SPRC
Tags
CMNDF
Clearmind Medicine
Market News
From
Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
August 12, 2022
Tickers
SPRC
Tags
SciSparc
Market News
Penny Stocks
From
Benzinga
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
July 20, 2022
Tickers
BIIB
LLY
PFE
SAVA
Tags
SciSparc
Penny Stocks
PFE
From
Benzinga
SciSparc Announces Buyback Equal To 12% Of Float
July 07, 2022
Tickers
SPRC
Tags
Partner Content
Benzinga
Buybacks
From
Benzinga
SciSparc Completes Development Of Its Proprietary Drug Candidate SCI-110 To Treat Tourette Syndrome
June 30, 2022
Tickers
SPRC
Tags
Biotech
Partner Content
Benzinga
From
Benzinga
SciSparc Successfully Completed The Development Of Its Proprietary Drug Candidate SCI-110 For Its Upcoming Phase IIb Study In Tourette Syndrome
June 29, 2022
Tickers
SPRC
Tags
SciSparc
Market News
Press Releases
From
Benzinga
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
June 28, 2022
Tickers
ABC
CAH
JNJ
MCK
Tags
SciSparc
MCK
SPRC
From
Benzinga
SciSparc Receives Ethics Committee Approval To Conduct Clinical Trial In ASD With Proprietary SCI-210 Treatment
June 24, 2022
Tickers
SPRC
Tags
General
Biotech
Partner Content
From
Benzinga
SciSparc Announces Ethics Committee Approval To Conduct Its Clinical Trial In Autism Spectrum Disorder
June 23, 2022
Tickers
SPRC
Tags
SPRC
Press Releases
Penny Stocks
From
Benzinga
SciSparc Reinforces Its New JV For Targeting Discovery With A Global Expert In The Field Of Mitochondrial Transport Proteins
June 15, 2022
Tickers
SPRC
Tags
General
Biotech
Partner Content
From
Benzinga
Initial Positive Results For Cocaine Addiction Treatment Announced
June 08, 2022
Tickers
SPRC
Tags
General
Biotech
Partner Content
From
Benzinga
SciSparc Ltd. Announces Initial Positive Results For The Cocaine Addiction Treatment Of Clearmind Medicine Inc.
June 07, 2022
Tickers
CMNDF
SPRC
Tags
CMNDF
General
Partner Content
From
Benzinga
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
June 02, 2022
Tickers
CMNDF
SPRC
Tags
SciSparc
Market News
Penny Stocks
From
Benzinga
SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems
May 31, 2022
Tickers
SPRC
Tags
Partner Content
Benzinga
Biotech
From
Benzinga
SciSparc Gets Ethics Committee Approval In Germany And Israel Sites To Conduct A Phase IIb Trial In Tourette Syndrome
May 27, 2022
Tickers
SPRC
Tags
Benzinga
Partner Content
Biotech
From
Benzinga
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial In Tourette Syndrome
May 26, 2022
Tickers
SPRC
Tags
Benzinga
Partner Content
Biotech
From
Benzinga
Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients
May 25, 2022
Tickers
JNJ
RDY
SPRC
Tags
Benzinga
JNJ
Partner Content
From
Benzinga
SciSparc And Clearmind Medicine Inc. Collaboration Yields Positive Results For Its Psychedelic Combination Treatment
May 24, 2022
Tickers
SPRC
Tags
SPRC
Press Releases
Psychedelics
From
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Tickers
ABC
JNJ
SPRC
Tags
Benzinga
Markets
JNJ
From
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Tickers
ABC
JNJ
SPRC
Tags
Benzinga
Markets
JNJ
From
Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
May 17, 2022
Tickers
SPRC
Tags
SPRC
Penny Stocks
Press Releases
From
Benzinga
Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested
May 13, 2022
Tickers
CMNDF
SPRC
Tags
Clearmind Medicine Inc/
Cannabis
Markets
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.